medigraphic.com
ISSN 0210-5187 (Electronic)

2005, Number 4

<< Back Next >>

Med Cutan Iber Lat Am 2005; 33 (4)

Livedoid vasculitis with antiphospholipid antibodies

Levy BA, Antunes JR, Moritz TB, Ribeiro LME, Cuzzi T, Torres BAC

Language: Portugués
References: 20
Page: 175-177
PDF size: 249.00 Kb.


ABSTRACT

The authors report a case of a 19-year-old woman presenting livedoid vasculitis. This is a painfull clinical entity, characterized by purpuric lesions with shaped ulcers and atrophie blanche. Raised anticardiolipin antibody titers are associated at the present case. The ethiopatogenic mecanisms and the different denominations for the disease are discussed.


REFERENCES

  1. Bard JW, Winkelman RK. Livedo vasculitis: segmental hyalinizing vasculitis of the dermis. Arch Dermatol. 1967;96:489-99.

  2. Milstone LM, Braverman IM, Lucky P, Fleckman P. Classification and therapy of atrophie blanche. Arch Dermatol 1983; 119:963-9.

  3. Acland KM, Darvay A, Wakelin SH, Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol 1999;140:131-5.

  4. Papi M, Didona B, De Pità O, et al. Livedo vasculopathy vs Small Vessel Cutaneous Vasculitis. Arch Dermatol 1998;134:447-52.

  5. Milian G. Les atrophies cutanees syphilitiques. Bull Soc Fr Dermatol Syphilol 1929;36:865-71.

  6. Jorizzo JL. Livedoid Vasculopathy- What is it? Arch Drematol 1998;134:491-3.

  7. Grasland A, Crickx B, Blanc M, Pouchot J, et al. Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies. Ann Med Interne 2000;151:408-10.

  8. McCalmont CS, McCalmont TH, Jorizzo JL, White WL, et al. Livedo vasculitis: vasculitis or thrombotic vasculopathy? Clin Exp Dermatol 1992;17:4-8.

  9. Calamia KT, Balabanova M, Perniciaro C, Walsh JS. Livedo (livedoid) vasculitis and the factor V Leiden mutation: Additional evidence for abnormal coagulation. J Am Acad Dermatol 2002;46:133-7.

  10. Pizzo Sv, Murray JC, Gonias SL. Atrophie blanche. A disorder associated with defective release of tissue plasminogen activator. Arch Pathol Lab Med 1986;110:517-9.

  11. Schroeter AL, Diaz-Perez J, Winkelmann RK, Jordon RE. Livedo vasculitis (the vasculitis of atrophie Blanche)- Immunohistopathologic study. Arch Dermatol 1975;111:188-93.

  12. Gibson GE, Pittelkow MR. Antiphospholipid syndrome and the skin. J Am Acad Dermatol 1997;36:970 -82.

  13. Drucker CR, Duncan WC. Antiplatelet therapy in atrophie blanche and livedo vasculitis. J Am Acad Dermatol 1982;7:359- 63.

  14. Hsiao GH, Chiu HC. Low-dose danazol in the treatment of livedoid vasculitis. Dermatology. 1997;194:251-5.

  15. Purcell SM, Hayes TJ. Nifedipine treatment of idiopathic atrophie blanche. J Am Acad Dermatol 1986;14:851-4.

  16. Jetton RL, Lazarus GS. Minidose heparin therapy for vasculitis of atrophie blanche. J Am Acad Dermatol 1983;8:23- 6.

  17. Choi HJ, Hann SK. Livedo reticularis and livedoid vasculitis responding to PUVA therapy. J Am Acad Dermatol 1999;40: 204-7.

  18. Sauer GC. Pentoxifylline (Trental) therapy for the vasculitis of atrophie blanche. Arch Dermatol 1986;22:380 -1.

  19. Sams WM Jr. Livedo vasculitis: therapy with pentoxifylline. Arch Dermatol 1988;124:

  20. 684-7.




2020     |     www.medigraphic.com